Filter Results:
(44)
Show Results For
- All HBS Web (44)
- Faculty Publications (7)
Show Results For
- All HBS Web (44)
- Faculty Publications (7)
Page 1 of 44
Results →
- Editorial
Assessment of Economic Vulnerability to Infectious Disease Crises
By: Peter A Sands, Anas El Turabi, Philip Saynisch and Victor J Dzau
Sands, Peter A., Anas El Turabi, Philip Saynisch, and Victor J Dzau. "Assessment of Economic Vulnerability to Infectious Disease Crises." Lancet 388, no. 10058 (November 12, 2016): 2443–2448.
- Article
Measuring the Scientific Effectiveness of Contact Tracing: Evidence from a Natural Experiment
By: Thiemo Fetzer and Thomas Graeber
Contact tracing has for decades been a cornerstone of the public health approach to epidemics, including Ebola, severe acute respiratory syndrome, and now COVID-19. It has not yet been possible, however, to causally assess the method’s effectiveness using a randomized... View Details
Fetzer, Thiemo, and Thomas Graeber. "Measuring the Scientific Effectiveness of Contact Tracing: Evidence from a Natural Experiment." Proceedings of the National Academy of Sciences 118, no. 33 (August 17, 2021): 1–4.
- 29 Apr 2020
- News
What Makes an Office Building “Healthy”
- 09 Jun 2020
- Working Paper Summaries
Aggregate and Firm-Level Stock Returns During Pandemics, in Real Time
- 2022
- Report
The First Four Healthy Building Strategies Every Building Should Pursue to Reduce Risk from COVID-19
By: Joseph G. Allen, Emily Jones, Marissa V. Rainbolt, Linsey C. Marr, David Michaels, Leslie R. Cadet, Shelly L. Miller, Meira Levinson, Lidia Morawska, Richard L. Corsi, Nira R. Pollock, Yuguo Li, Alasdair P.S. Munro, Kelly Grier, Qingyan Chen, John D. Macomber and Xiaodong Cao
Understanding of the most probable transmission routes and identifying the risk environments for disease spread should always be among the first critical steps in the response to future disease threats. This is one of the most vital public health lessons of the... View Details
Keywords: Health Pandemics; Buildings and Facilities; Risk and Uncertainty; Health Industry; Education Industry; Real Estate Industry
Allen, Joseph G., Emily Jones, Marissa V. Rainbolt, Linsey C. Marr, David Michaels, Leslie R. Cadet, Shelly L. Miller, Meira Levinson, Lidia Morawska, Richard L. Corsi, Nira R. Pollock, Yuguo Li, Alasdair P.S. Munro, Kelly Grier, Qingyan Chen, John D. Macomber, and Xiaodong Cao. "The First Four Healthy Building Strategies Every Building Should Pursue to Reduce Risk from COVID-19." Report, Lancet COVID-19 Commission, Task Force on Safe School, Safe Work, Safe Travel, July 2022. (COVID-19 Commission.)
The First Four Healthy Building Strategies Every Building Should Pursue to Reduce Risk from COVID-19
The Lancet COVID-19 Commission was an interdisciplinary initiative encompassing the health sciences, business, finance, and public policy. The Lancet COVID-19... View Details
- 09 Jun 2020
- News
Fed action, debt markets and stocks
- Article
The Unprecedented Stock Market Reaction to COVID-19
By: Scott Baker, Nicholas Bloom, Steven J. Davis, Kyle Kost, Marco Sammon and Tasaneeya Viratyosin
No previous infectious disease outbreak, including the Spanish Flu, has impacted the stock market as forcefully as the COVID-19 pandemic. In fact, previous pandemics left only mild traces on the U.S. stock market. We use text-based methods to develop these points with... View Details
Baker, Scott, Nicholas Bloom, Steven J. Davis, Kyle Kost, Marco Sammon, and Tasaneeya Viratyosin. "The Unprecedented Stock Market Reaction to COVID-19." Review of Asset Pricing Studies 10, no. 4 (December 2020): 742–758.
What Makes a Building Healthy?
The pandemic spawned by the novel coronavirus has forced a global reckoning with the awesome power of infectious diseases to grind economies to a halt. The forced lockdowns and retreat into home isolation has also given us a heightened awareness of the role our... View Details
- 07 Feb 2012
- First Look
First Look: February 7
Products in China for China Vicki L. Sato, Christoph Jaeker, and Kareem RedaHarvard Business School Case 612-032 Sym-Bio, an entrepreneurial Chinese diagnostic company with a product line in infectious View Details
Keywords: Sean Silverthorne
- 14 Jul 2023
- Blog Post
Harvard Business School Announces Its 2023-2024 Blavatnik Fellows
synthetic biology and data science company that’s digitizing taste and smell. Morgan previously ran business development and fundraising at Trellis Bioscience, a clinical-stage Series C startup developing rare native human antibodies against View Details
- Web
Profiles - MBA
access to accurate medical information for first responders, cost-effective methods to diagnose diabetic retinopathy and glioblastoma, and resource allocation for healthcare workers in infectious disease... View Details
- 01 Mar 2024
- News
On the Radar
Illustration by Brian Stauffer Illustration by Brian Stauffer Our planet is teeming with trillions of viruses and bacteria, most of which are innocuous or even helpful, but some pose a significant risk to public health, animals, and crops. In recent decades,... View Details
- 31 Jan 2014
- News
Body, Heal Thyself
according to the New York Times. Then, in October, the government's Defense Advanced Research Projects Agency (DARPA) awarded Moderna $25 million to develop mRNA to combat infectious diseases and biological... View Details
- 01 Jun 2023
- News
From Big Pharma to Startup
people with disabling hearing loss Buoy Health—provides AI-powered feedback on symptoms and makes recommendations for care options Careport Health—offers care coordination software solutions to manage patient transitions across the continuum Day Zero... View Details
Keywords: April White
- 02 Jun 2021
- Research & Ideas
A Rare Find in Health Care: A Simple Solution to Racial Inequity
are within our grasp." “Although we don’t have as much data on the quality of COVID care, I’m quite sure there are much greater quality differences across hospitals in treating COVID than heart attacks,” he says. “In Boston, the leading academic medical centers, with a... View Details
- 13 Nov 2013
- Research & Ideas
Should Men’s Products Fear a Woman’s Touch?
Most eight-year-olds are familiar with cooties: an imaginary infectious disease spread through proximity to children of the opposite sex. We eventually outgrow the silly idea. But when it comes to the world... View Details
- 25 Apr 2014
- News
A revolution in healing
government's Defense Advanced Research Projects Agency awarded Moderna funding to develop mRNA to combat infectious diseases and biological threats. (Published April 2014) View Details
Charles A. Heimbold, Jr.
Heimbold focused on Bristol-Myers Squibb’s growth and created a scientific-based, world-leading pharmaceutical company with very strong consumer franchises. Sixty-two percent of its sales come from pharmaceuticals (where it holds leadership positions in anticancer... View Details
Keywords: Healthcare
- 31 Oct 2014
- Op-Ed
Ebola’s Call To Arms About Disaster Preparedness
need someone like that because, while the Center for Disease Control has fantastic scientists, management has never been their main skill set. “The goal should be to optimize to mitigate catastrophes while managing routine concerns... View Details